#ASCO25 Day 2: so proud of our two stellar residents, soon to be fellows! @Meddoc77 (Himil Mahadevia) and Parth Sharma. Congrats on the posters, can’t wait to see what your futures hold! @SLCI_KC@saintlukeskc
Took a page out of @CathyEngMD ‘s book and opened @ASCO 2025 with a morning lake run! Excited to be in Chicago and ready to learn and catch up w friends!
Happy to work in a practice with great people that enjoy blowing off some steam at the end of the week. Cheers to many more happy hours! @saintlukeskc@SLCI_KC
Calling all thoracic oncologists - Saint Luke’s in Kansas City is hiring! We have robust precision and research programs. DM me to get more information on how to join the wonderful folks in our practice! https://t.co/18KXBkYLNa @saintlukeskc
Join us alongside gastrointestinal medical oncologist @MarcRothMD of @StLukesSTL April 25 at 1pm EST for a deep dive into biomarker testing and how it fits into your care plan!
Register today!
https://t.co/oYApRMGGIO
Our correspondence is now available on @TheLancet!
Differences in HCC etiology may contribute to the positive result of camrelizumab plus rivoceranib in CARES-310 trial, in contrast to other IO+TKI trials. Thank you @MarcRothMD@SLCI_KC for the support.
https://t.co/S1MkcfiOrR
Excited to join Total Health as a speaker at their upcoming 2024 ASCO Direct Kansas City Conference! I’ll be discussing colorectal cancer highlights. Hope to see you there! @TotalHealthConf@saintlukeskc@ASCO
Had a great time celebrating the @KCCurrentFC win this week! So lucky to have such great oncology colleagues and friends. Thanks to @saintlukeskc for the suite, right between @PatrickMahomes & Andy Reid! #worklifebalance
Messi may be in KC, but @KristenCiombor is the real star! It was great catching up with her and learning from her at the KS @OSSatACCC Spring Mtg. @VUMCHemOnc
Please consider donating to my sisters non-profit, @prckcmo, a local KC organization that supports pets in countless ways! They have helped feed and rehome a number of my cancer patient’s pets in a time of need. Check them out! @SLCI_KC@saintlukeskc@GildasClubKC Link Below
The day we’ve been waiting for! @US_FDA approves fruquitinib for refractory met #colorectal#cancer providing another option for our patients! Thank you to mentor @CathyEngMD and others on this tremendous effort! @SLCI_KC@saintlukeskc
https://t.co/KIZwvMAvOX
Check out our new case report on a patient w #colorectal#cancer and a T790M mutation who responded to targeted therapy w osimertinib. Collab between @SLCI_KC Center for Precision Oncology and @UMKC. https://t.co/E5GjDBpFgy @dhruvsxu @JBuckleyMD @saintlukeskc#teamsaintlukes